We assessed the ability of plasma proenkephalin (p‐PENK) and plasma neutrophil gelatinase-associated lipocalin (p‐NGAL) to predict 28-day mortality in AKI patients in intensive care. The gene discussed is PENK; the disease is acute kidney injury.